ALNY icon

Alnylam Pharmaceuticals

472 hedge funds and large institutions have $22.5B invested in Alnylam Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 163 increasing their positions, 152 reducing their positions, and 54 closing their positions.

Holders
472
Holders Change
Holders Change %
0%
% of All Funds
7.44%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
55
Increased
163
Reduced
152
Closed
54
Calls
$119M
Puts
$162M
Net Calls
-$42.2M
Net Calls Change
-$77M
Name Market Value Shares Shares
Change
Shares
Change %
GCP
501
GSA Capital Partners
United Kingdom
-1,042 Closed
WSTAM
502
Wilbanks Smith & Thomas Asset Management
Virginia
-1,000 Closed
NSEDCP
503
NJ State Employees Deferred Compensation Plan
New Jersey
-1,000 Closed
WP
504
Westmount Partners
California
-1,000 Closed
CF
505
Centaurus Financial
California
-752 Closed
CG
506
Cutler Group
California
-600 Closed
PP
507
Paloma Partners
Connecticut
-531 Closed
SI
508
Sofinnova Investments
California
-448 Closed
UCB
509
United Community Bank
South Carolina
-401 Closed
ASN
510
Advisory Services Network
Georgia
-273 Closed
BAM
511
Belpointe Asset Management
Nevada
-105 Closed
ANBT
512
American National Bank & Trust
Texas
-66 Closed
TWA
513
TCI Wealth Advisors
Arizona
-38 Closed
SSC
514
Syverson Strege & Co
Iowa
-14 Closed
SFG
515
Steward Financial Group
Texas
-12 Closed
BCMLT
516
Beacon Capital Management LLC (Tennessee)
Tennessee
-10 Closed
GBT
517
Grove Bank & Trust
Florida
-6 Closed
SC
518
Schubert & Co
Texas
-5 Closed
AAS
519
Ameritas Advisory Services
Nebraska
-4 Closed
ME
520
McIlrath & Eck
Washington
-3 Closed
TAIM
521
TD Ameritrade Investment Management
Nebraska
-3 Closed
Optiver Holding
522
Optiver Holding
Netherlands
-2 Closed
BWM
523
BerganKDV Wealth Management
Minnesota
-2 Closed
PTC
524
Private Trust Company
Ohio
-1 Closed
CFGS
525
Concourse Financial Group Securities
Alabama